NCT03136094 Suicide in Urban Natives: Detection and Networks to Combat Events
| NCT ID | NCT03136094 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Colorado, Denver |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 698 participants |
| Start Date | 2020-03-15 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 698 participants in total. It began in 2020-03-15 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study compares the effectiveness of a program to detect and manage suicide risk among American-Indian and Alaska Native (AI/AN) youth. Half of the participants will receive caring text messages to reduce suicidal thoughts, attempts, and hospitalizations and to increase engagement, social connectedness, and resilience in at-risk youth. The other half will receive usual care that does not include the caring text messages.
Eligibility Criteria
Inclusion Criteria: * Self-identify as American Indian or Alaska Native; * Screen positive for mild, moderate, or severe risk of suicidality (referred by a clinical provider); * Have a text-enabled mobile phone; * Willing to be contacted by text; * Able to participate voluntarily; * Speak and read English; * Cognitively able to independently provide written informed consent Exclusion Criteria: * Under age 18 * In danger of imminent self-harm; * Hospitalized
Contact & Investigator
Spero Manson, PhD
PRINCIPAL INVESTIGATOR
University of Colorado, Denver
Frequently Asked Questions
Who can join the NCT03136094 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 34 Years, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03136094 currently recruiting?
Yes, NCT03136094 is actively recruiting participants. Contact the research team at erin.poole@CUAnschutz.edu for enrollment information.
Where is the NCT03136094 trial being conducted?
This trial is being conducted at Albuquerque, United States.
Who is sponsoring the NCT03136094 clinical trial?
NCT03136094 is sponsored by University of Colorado, Denver. The principal investigator is Spero Manson, PhD at University of Colorado, Denver. The trial plans to enroll 698 participants.